Németh Krisztina, Tóth Blanka, Sarnyai Farkas, Koncz Anna, Lenzinger Dorina, Kereszturi Éva, Visnovitz Tamás, Kestecher Brachyahu Meir, Osteikoetxea Xabier, Csala Miklós, Buzás Edit I, Tamási Viola
Department of Genetics, Cell- and Immunobiology, Semmelweis University, Nagyvárad Tér 4, Budapest, 1085, Hungary.
ELKH-SE Translational Extracellular Vesicle Research Group, Nagyvárad Tér 4, Budapest, 1085, Hungary.
Nutr Metab (Lond). 2023 Mar 31;20(1):19. doi: 10.1186/s12986-023-00738-z.
High fat diet (HFD) increases the likelihood of dyslipidemia, which can be a serious risk factor for atherosclerosis, diabetes or hepatosteatosis. Although changes in different blood lipid levels were broadly investigated, such alterations in the liver tissue have not been studied before. The aim of the current study was to investigate the effect of HFD on hepatic triglyceride (TG), diglyceride (DG) and ceramide (CER) levels and on the expression of four key genes involved in lipid homeostasis (Pcsk9, Ldlr, Cd36 and Anxa2) in the liver. In addition, the potential role of PCSK9 in the observed changes was further investigated by using PCSK9 deficient mice.
We used two in vivo models: mice kept on HFD for 20 weeks and PCSK9 mice. The amount of the major TGs, DGs and CERs was measured by using HPLC-MS/MS analysis. The expression profiles of four lipid related genes, namely Pcsk9, Ldlr, Cd36 and Anxa2 were assessed. Co-localization studies were performed by confocal microscopy.
In HFD mice, hepatic PCSK9 expression was decreased and ANXA2 expression was increased both on mRNA and protein levels, and the amount of LDLR and CD36 receptor proteins was increased. While LDLR protein level was also elevated in the livers of PCSK9 mice, there was no significant change in the expression of ANXA2 and CD36 in these animals. HFD induced a significant elevation in the hepatic levels of all measured TG and DG but not of CER types, and increased the proportion of monounsaturated vs. saturated TGs and DGs. Similar changes were detected in the hepatic lipid profiles of HFD and PCSK9 mice. Co-localization of PCSK9 with LDLR, CD36 and ANXA2 was verified in HepG2 cells.
Our results show that obesogenic HFD downregulates PCSK9 expression in the liver and causes alterations in the hepatic lipid accumulation, which resemble those observed in PCSK9 deficiency. These findings suggest that PCSK9-mediated modulation of LDLR and CD36 expression might contribute to the HFD-induced changes in lipid homeostasis.
高脂饮食(HFD)会增加血脂异常的可能性,而血脂异常可能是动脉粥样硬化、糖尿病或肝脂肪变性的严重危险因素。尽管对不同血脂水平的变化进行了广泛研究,但此前尚未对肝组织中的此类改变进行研究。本研究的目的是探讨高脂饮食对肝脏甘油三酯(TG)、甘油二酯(DG)和神经酰胺(CER)水平以及对肝脏中参与脂质稳态的四个关键基因(Pcsk9、Ldlr、Cd36和Anxa2)表达的影响。此外,通过使用PCSK9缺陷小鼠进一步研究了PCSK9在观察到的变化中的潜在作用。
我们使用了两种体内模型:高脂饮食喂养20周的小鼠和PCSK9小鼠。使用HPLC-MS/MS分析测量主要甘油三酯、甘油二酯和神经酰胺的含量。评估四个脂质相关基因,即Pcsk9、Ldlr、Cd36和Anxa2的表达谱。通过共聚焦显微镜进行共定位研究。
在高脂饮食小鼠中,肝脏PCSK9表达在mRNA和蛋白质水平均降低,ANXA2表达增加,低密度脂蛋白受体(LDLR)和CD36受体蛋白的量增加。虽然PCSK9小鼠肝脏中的LDLR蛋白水平也升高,但这些动物中ANXA2和CD36的表达没有显著变化。高脂饮食导致所有测量的甘油三酯和甘油二酯的肝脏水平显著升高,但神经酰胺类型未升高,并增加了单不饱和甘油三酯与饱和甘油三酯和甘油二酯的比例。在高脂饮食和PCSK9小鼠的肝脏脂质谱中检测到类似变化。在HepG2细胞中证实了PCSK9与LDLR、CD36和ANXA2的共定位。
我们的结果表明,致肥胖的高脂饮食下调肝脏中PCSK9的表达,并导致肝脏脂质积累的改变,这与PCSK9缺乏时观察到的情况相似。这些发现表明,PCSK9介导的LDLR和CD36表达调节可能导致高脂饮食诱导的脂质稳态变化。